SFTPA2 and acute respiratory distress syndrome: Finally, the authors identified the SFTPA2 haplotype 1A1 to be protective for a number of indicators (acute respiratory failure, acute respiratory distress syndrome, PaO2/FiO2 ratio, and mechanical ventilation), suggesting that this variant may be examined for future therapy against pandemic H1N1.